- Atlex Stockyards Website
Cattle biologics are defined as the vaccines, bacterins, diagnostics etc which helps to prevent, diagnose or treat the disease conditions in cattle and calves. These product works through some immunological pathway. The cattle biologics manufacturing market consist of four major segments on the basis of the products namely:
-
Vaccines
-
Pre-breeding vaccines for calves
-
Antibodies
-
Diagnostic kits
Among these categories, vaccines and pre-breeding vaccines for calves capture the major share of the market. Vaccines are provided to both cattle and calves, especially the new born calves to save them from various diseases such as clostridial diseases, anthrax, bovine virus diarrhea and vibriosis. On the basis of type of manufacturing the cattle biologics manufacturing market is divided into four main categories which include:
-
Bacterins
-
Bacterin Toxoid
-
Non-bacterins
-
Custom made Vaccines
Bacterins include vaccines which are made from killed bacteria, while the bacterin toxoids include vaccines which are made from live bacteria. In cattle vaccination, bacterin toxoid is preferred over other vaccination due to its long lasting effect. Texas Vet Lab, Inc. is one of the major market players of bacterins and bacterin toxoid and it is offering a wide range of products in its portfolio such as moraxella ovis, unique serovars of Salmonella and Histophilus Somni. Custom-made vaccines are also capturing a major part of the cattle biologics manufacturing market and have been complement to “off-the-shell” products in the U.S. market. Custom-made vaccines are the vaccines which are manufactured from the specific virus or bacteria which is major cause of disease in livestock operation. Newport Laboratories is one of the market players which is offering custom-made vaccines to the producers and veterinarians which gives them option to prepare a mixture of different products, modified according to producer that is not commercially available.
Download Brochure of this Report:
Pre-breeding vaccination includes the vaccines, which are given to calves at the age between 12 months to 15 months. These vaccines are provided to calves to protect them against common reproductive diseases. On the basis of the vaccines which are provided to the calves, cattle biologics manufacturing market is divided into six major classes:
-
Bovine Viral Diarrhea (BVD)
-
Infectious Bovine Rhinotracheitis (IBR)
-
Leptospirosis
-
Bovine respiratory syncytial virus (BRSV)
-
Clostridium
-
Trichomoniasis
Among these the bovine viral diarrhea is most commonly used vaccine followed by leptospirosis and trichomoniasis. All these pre-breeding vaccinations protect calves from delayed breeding, smaller calves, potential abortions and persistently infected calves.
North America and Europe currently lead the cattle biologics manufacturing market majorly due to strong economic conditions and large number of cattle population. The major market of Europe is driven by Switzerland, which is known for cows and cattle. In 2010, there were 1,591, 233 cattle in Switzerland. Additionally, the government of U.S. and Europe has also setup some regulatory firms which are also helping the market to grow. As in Canada, the Canadian Food Inspection Agency (CFIA) regulates veterinary biologics and animal health products such as antibody products, vaccines, diagnostic kits that are used for the prevention, treatment and diagnosis of infectious diseases in animals. Other major market players in cattle biologics market include Addison Cattle Corporation, Agrilabs, Biocor Animal Health, Inc., Boehringer Ingelheim, Colorado Serum Company, Durvet, Inc., Fort Dodge Animal Health, Merial, Novartis AG and Pfizer, Inc.
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free 866-552-3453
Email:sales@transparencymarketresearch.com
Website: